Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-29 @ 9:53 PM
Study NCT ID:
NCT01943292
Status:
COMPLETED
Last Update Posted:
2017-03-09
First Post:
2013-09-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies
Sponsor:
Verastem, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-11
First Submit QC Date:
None
Study First Post Date:
2013-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-09
Results First Submit QC Date:
None
Results First Post Date:
2015-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-26
Last Update Post Date:
2017-03-09
Last Update Post Date Type:
ACTUAL